Company Filing History:
Years Active: 2008-2009
Title: Yi-Pei Chen: Innovator in Biotechnology
Introduction
Yi-Pei Chen is a prominent inventor based in Yingge, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the area of cholesterol inhibitors and retrotransposons. With a total of 2 patents, his work has implications for both health and agricultural biotechnology.
Latest Patents
Yi-Pei Chen's latest patents include groundbreaking research on Monacolin K biosynthesis genes. This invention focuses on cholesterol inhibitors produced by Monacolin K, a secondary metabolite of polyketides. The invention provides probes specific to the Monacolin K biosynthesis gene cluster. BAC clones containing the putative Monacolin K gene cluster were screened from a BAC (bacterial artificial chromosome) library, followed by sequencing and annotation of these clones. The results revealed the presence of 2 polyketide synthase (PKS) genes and 7 regulatory genes related to Monacolin K synthesis. Full-length cDNAs of these genes were subsequently obtained through RT-PCR and cloned into expression vectors for further study.
Another significant patent involves fungi non-LTR retrotransposons and methods related to them. This retrotransposon comprises a nucleotide sequence selected from a group that includes several specific sequences. The invention provides insights into the mechanisms of retrotransposons, which can have various applications in genetic research and biotechnology.
Career Highlights
Yi-Pei Chen is affiliated with the Food Industry Research and Development Institute, where he continues to advance his research in biotechnology. His work has not only contributed to scientific knowledge but also has practical applications in the food industry and health sectors.
Collaborations
Some of his notable coworkers include Li-Ling Liaw and Chun-Lin Wang. Their collaborative efforts have further enhanced the research output and innovation at the institute.
Conclusion
Yi-Pei Chen's contributions to biotechnology through his patents and research are noteworthy. His work on Monacolin K and retrotransposons showcases the potential for innovation in health and agricultural applications. His ongoing research continues to pave the way for future advancements in the field.